stimulation for assessment of adrenal function and the detection of mild adrenal insufficiency.
The criteria for normal response to are a peak cortisol level of more than 500 nmol/L (18.1 pg/dL) and an increment of the cortisol level above the basal one of more than 200 nmol/L (7.2 pg/dL). These criteria were satisfied by 32 of 33 healthy children and adults subjected to an dose 500 times lower (0. F OR THREE DECADES, the iv injection of a pharmacological dose (250 pg/1.73 m2) of ACTH-(l-24) has been used as a standard test in the initial assessment of adrenal function (l-3). However, pharmacological ACTH tests provide information only about the ability of the adrenals to respond to unusual stimuli and may not reflect the daily cortisol secretion or the response to minor stresses, such as mild infectious disease. Studies in healthy volunteers demonstrated that low doses (0.5-l pg/1.73 m*) of ACTH-(l-24) are sufficient to stimulate release of cortisol from the adrenal gland that will meet the standard criteria for a satisfactory ACTH test result (4,5). It has been suggested that the lowdose ACTH test could be a sensitive method to detect subtle impairment in adrenal function that would be masked when the standard test is used (5).
Findings from studies on occurrence of adrenal suppression in asthmatic patients treated with inhaled corticosteroids have been controversial; some investigators reported that there were no effects (6-91, and others claimed to have adrenal suppression at high doses (10,ll) or even at conventional doses of steroids (12-15). Many of these studies have relied on the pharmacological standard-dose ACTH test or on stress tests, such as insulin-induced hypoglycemia. The purpose of this work was to study the role of the low-dose ACTH-(l-24) test in assessment of adrenal function in healthy children and young adults and to evaluate the possibility that it is a more sensitive method for detection of impaired adrenal function in asthmatic patients treated with inhaled corticosteroids.
Subjects and Methods

Subjects
Forty-six asthmatic patients comprised of 30 children (22 male, 8 female, aged 5-14 yr) and 16 adults (10 male, 6 female, aged 18-30 yr) took part in this study. Fifteen children (12 male, 3 female, aged 6-14 yr) referred to our Pediatric Endocrinology Clinic for investigation of short stature and 18 medical students (12 male, 6 female, aged 22-26 yr) served as a control group. The children were matched for age, and the young adults were matched for age and sex. Thirty-two of the asthmatic patients were taking inhaled beclomethasone dipropionate, 148-1198 pg/rn' daily (mean 482 2 42); 14 inhaled budesonide, 250-1058 Fg/m' daily (mean 507 2 62), divided into 2-3 doses per day for more than 6 months.
All used metered-dose inhalers.
Patients were excluded from the study if they had been treated with oral steroids during the 6 months preceding the study. 
Results
Low ACTH test in healthy untreated controls
The mean serum cortisol concentration attained in healthy controls 20 min after stimulation with 0.5 pg ACTH-(l-24)/ 1.73 m2 [(621 t 28 nmol/L) (22.5 +-1.0 &dL)l was similar to that produced at the same time by the standard pharmacological dose of 250 pg [(654 * 31 nmol/L) (23.7 '-1.1 pg/dL)l. Serum cortisol levels continued to rise 45 min after stimulation with the high dose but fell 30 min after administration of the lower dose (Fig. 1) . Although the mean peak serum cortisol response to 0.5 pg ACTH-(l-24)/1.73 m2 [(571 ? 23 nmol/L) (20.7 t 0.8 pg/dL)l and the incremental rise in cortisol I(274 + 17 nmol/L) (9.9 2 0.6 pgldL)I were lower than those produced in response to the standard dose of 250 kg [(698 -C 32) (25.3 2 1.1) and 372 t 20 nmol/L (13.5 + 0.7 Fg/dL), respectively], the results indicate that the lower dose is sufficient to stimulate release of cortisol from the adrenal gland, which meets the criteria for a satisfactory ACTH test. Indeed, in 32 of 33 controls, the peak cortisol response to the lower dose was more than or equal to 500 nmol/L (18.1 pg/dL), and the rise in serum cortisol from basal values was more than or equal to 200 nmol/L (7.2 kg/dL) in all controls.
Low-dose ACTH test in asthmatic patients taking inhaled corticosteroids
Mean serum cortisol responses at 20, 30, and 45 min to stimulation with 0.5 pg/1.73 m2 ACTH-(1-24) were significantly lower in patients taking inhaled corticosteroids than in untreated controls (Fig. 1) . In 16 of 46 patients (35%, 10 of 30 children and 6 of 16 young adults) peak serum cortisol levels following stimulation with the low dose of ACTH-(l-24) were less than 500 nmol/L (18.1 wg/dL) and, of these, 11 (24%, 7 of 30 children and 4 of 16 young adults) had also an incremental rise in cortisol of <200 nmol/L (7.2 pg/dL). In these 11 patients, a repeat ACTH stimulation test with the standard dose of 250 pg/1.73 m* gave a normal response in all but one case (Fig. 2) .
Urinary free cortisol
There was a positive correlation between the peak cortisol response to 0.5 pg ACTH-(1-24) and the 24-h urinary cortisol excretion (r = 0.455, P < 0.002). Furthermore, those patients who failed to pass the low-dose ACTH test had lower 24-h urinary free cortisol concentration [(71 t 10 nmol/m' * 24 h) (25.7 t 3.6 pg/rn' * 24 h)] than the patients who responded normally [(118 2 11 nmol/m2 * 24 h) (42.8 2 4.0 pg/rn'* 24 h)] (Fig. 3) . No significant correlation was found between the daily dose of inhaled corticosteroids and the peak cortisol response to low-dose ACTH stimulation or urinary free cortisol excretion.
Discussion
Inhaled corticosteroid therapy is based on the premise that the untoward systemic side effects will be minimized. However, there is still controversy in the literature as to the extent of adrenal suppression. Previous reports demonstrated adequate responsiveness to the standard pharmacological ACTH test in patients taking conventional doses of inhaled corticosteroids (6) (7) (8) 14) . A poor cortisol response was usually not encountered at corticosteroid doses of less than 1800-2000 pg daily (10-12). In the present study, the use of the low-dose ACTH test has demonstrated reduced adrenal response in approximately one-quarter of patients treated with doses of corticosteroids within the conventional limits. Although 11 of 46 patients showed reduced adrenal reserve in the low-dose ACTH test, all but one case gave normal responses to the standard test (250 pg ACTH), and would, therefore, have been regarded as having been unaffected. Low values of urinary free cortisol in those who responded poorly to low-dose ACTH, compared with a much higher mean of those who responded positively, provides further evidence that the poor responders to low-dose ACTH were indeed those with impaired adrenal function.
Our observation that no correlation was found between the daily dose of inhaled corticosteroids and the peak serum cortisol concentration or urinary free cortisol excretion agrees with previous reports (14, 15, 19) , which suggest that in some patients even small doses of inhaled corticosteroids may cause impaired adrenal function whereas other patients are affected only by high doses.
Several investigators have suggested that the standard dose of ACTH used in the adrenal stimulation test far exceeds the amount required to induce a sufficient cortisol response (20-23). Nevertheless, these observations, expressed 30 yr ago by Landon et al. (22, 231,  have not brought about any change in the use of the high-dose test by the majority of endocrinologists. However, recent works have shown that doses 500 times lower than the standard dose of ACTH are sufficient to produce an adequate adrenal response (4,5). Indeed, these studies and the present one demonstrate that, 20 min after injection of 0.5 pg ACTH-(l-24), serum cortisol levels are similar to those observed after injection of the standard (250 pg) dose. The rise in serum cortisol in response to the low dose was of shorter duration, probably because of breakdown of ACTH in the body, which leaves too low an ACTH level to cause further adrenal stimulation. Interestingly, a major stress, such as insulin-induced hypoglycemia, involved an increase in plasma ACTH equivalent to an injection of about 5-7 pg (l-24)-ACTH (18). This report showed that ACTH levels more than 275 pg/mL do not result in a greater cortisol response but rather in prolongation of the cortisol secretion.
Our present results from tests performed on 79 children and adults have confirmed the suitability of the low-dose ACTH test. Furthermore, this test has been shown to be more sensitive than the standard high dose version, inasmuch as it demonstrates reduced adrenal reserve in steroid-treated asthmatic patients, a feature that was not detected in the standard test. The clinical significance of the low-dose test, therefore, appears to be early recognition of mild adrenal insufficiency, that might pose some danger in the presence of even mild stress. From our findings, we conclude that patients taking inhaled corticosteroids should be followed carefully. Those who respond poorly to low-dose ACTH stimulation may require prompt treatment with corticosteroids when under stressful conditions.
